FOXO4-DRI (10mg)
Experimental FOXO4-p53 Interaction Research Peptide
A D-retro-inverso experimental peptide studied in preclinical senescent-cell models through disruption of FOXO4-p53 interaction.
Research Applications & Benefits
- Senescence-pathway research
- FOXO4-p53 interaction studies
- D-retro-inverso peptide design
- Preclinical laboratory reagent
What is FOXO4-DRI?
A D-retro-inverso experimental peptide studied in preclinical senescent-cell models through disruption of FOXO4-p53 interaction.
Listed vial contents: 10mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
What mechanisms are being studied?
FOXO4-DRI was designed to interfere with FOXO4-p53 binding in senescent cells. In preclinical models this interaction was associated with p53 exclusion and apoptosis; translation beyond those models remains uncertain.
What are the research questions?
- Cellular-senescence pathway studies
- FOXO4/p53 protein-interaction research
- D-retro-inverso peptide pharmacology
What does the published work describe?
Baar et al. reported effects in cultured cells and aged-mouse models. This is early preclinical evidence, not proof of safety or efficacy in humans.
What are the limits of this evidence?
The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.
Study references
- Baar MP et al. Cell. 2017;169:132-147.e16
These are the catalog's existing bibliographic references. No new source verification is implied by this presentation.
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- FOXO4-DRI
- CAS Number
- N/A
- Molecular Weight
- ~5358 g/mol
- HPLC Purity Specification
- ≥99%
- Category
- Longevity
- Starting Price
- $149.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
FOXO4-DRI carries the purity specification shown above. Where a lot-specific CertikLabs Certificate of Analysis is available, the product page links its HPLC purity, LC-MS identity, and concentration results.
Frequently Asked Questions
Is FOXO4-DRI suitable for human consumption?
No. FOXO4-DRI is sold strictly for in-vitro laboratory research. It is not a drug, supplement, cosmetic, or food product and must not be administered to humans or animals.
What purity is FOXO4-DRI?
FOXO4-DRI carries a ≥99% HPLC purity specification. Check the product page for an available lot report.
How is FOXO4-DRI shipped and stored?
Vials are shipped lyophilized in temperature-controlled packaging. Store unopened lyophilized peptide at −20°C; once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
